These developments took place against the backdrop of public controversy over the approach towards the assessment and management of sensitive substances such as genetically modified organisms, and plant protection products, especially those containing glyphosate or potentially negative health impacts arising from endocrine disruptors.
Sve se to odvijalo u kontekstu kontroverzije u javnosti u pogledu načina na koji se pristupa procjeni osjetljivih tvari, primjerice genetski modificiranih organizama, i upravljanju tim tvarima te sredstvima za zaštitu bilja, osobito onima koja sadrže glifosate ili bi mogli negativno utjecati na zdravlje zbog endokrinih disruptora.